-
1
المؤلفون: IG Budaeva, EG Ovsyannikova, EN Goryunova, OV Kulemina, DV Zaitsev, DV Motorin, RSh Badaev, DB Zammoeva, VV Ivanov, KV Bogdanov, OS Pisotskaya, YuV Mirolyubova, TS Nikulina, YuA Alekseeva, AYu Zaritskey, LL Girshova
المصدر: Kliničeskaâ onkogematologiâ, Vol 12, Iss 3, Pp 289-296 (2019)
مصطلحات موضوعية: relapse, refractoriness, hemic and lymphatic diseases, acute myeloid leukemia, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, flag and flag-ida regimens, lcsh:RC254-282
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doajarticles::f7b59803d1c56f92d7d02553d8a676e5
https://doaj.org/article/5bf0b4c5df9f49f2a85bb1d94845554d -
2
المؤلفون: D.V. Zaitsev, YuV Mirolyubova, Konstantin Bogdanov, YuA Alekseeva, EN Goryunova, Darina Zammoeva, Larisa Girshova, EG Ovsyannikova, Irina Budaeva, AYu Zaritskey, OS Pisotskaya, TS Nikulina, Dmitry Motorin, O. Kulemina, RSh Badaev, VV Ivanov
المصدر: Clinical oncohematology. 12:289-296
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Regimen, business.industry, Internal medicine, Relapsed refractory, Medicine, FLAG (chemotherapy), Myeloid leukemia, In patient, Hematology, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::3eea6c0bf821bb326965581b4bf6d75e
https://doi.org/10.21320/2500-2139-2019-12-3-289-296 -
3
المؤلفون: OS Pisotskaya, Darina Zammoeva, Larisa Girshova, RSh Badaev, Konstantin Bogdanov, SO Kuzin, Dmitry Motorin, VV Ivanov, Irina Budaeva, EG Ovsyannikova, YuV Mirolyubova, TS Nikulina, YuA Alekseeva, AYu Zaritskii
المصدر: Kliničeskaâ onkogematologiâ, Vol 10, Iss 4, Pp 485-493 (2017)
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Acute myeloblastic leukemia, business.industry, Hematology, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, lcsh:RC254-282, acute myeloblastic leukemia, WT1, Correlation, NPM1 Mutation, AML, molecular monitoring, Internal medicine, Cancer research, Medicine, NPM1, In patient, business, Value (mathematics)
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00ef03b2957bf164694d1c0a35f673f2
https://doi.org/10.21320/2500-2139-2017-10-4-485-493 -
4
المؤلفون: YuV Mirolyubova, EG Ovsyannikova, YuA Alekseeva, EN Goryunova, IV Kholopova, TS Nikulina, Konstantin Bogdanov, AYu Zaritskii, SO Kuzin, VV Ivanov, Larisa Girshova, Dmitry Motorin, Alexey Petrov, R.I. Vabishchevich, DV Babenetskaya
المصدر: Kliničeskaâ onkogematologiâ, Vol 9, Iss 4, Pp 456-464 (2016)
مصطلحات موضوعية: 030213 general clinical medicine, RUNX1-RUNX1T1, business.industry, Hematology, 030204 cardiovascular system & hematology, Transcript level, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, lcsh:RC254-282, acute myeloblastic leukemia, 03 medical and health sciences, 0302 clinical medicine, Oncology, AML, molecular monitoring, hemic and lymphatic diseases, Runx1 runx1t1, Cancer research, Medicine, business
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3449e04c65d3107d58bc7870563f489d
http://bloodjournal.ru/en/molecular-monitoring-of-runx1-runx1t1-transcript-level-in-acute-myeloblastic-leukemias-on-treatment/